Table 2. In-hospital management.
| Total (N = 726) | STEMI (N = 404) | NSTEMI (N =322) | |
| In-hospital medical treatment (%) | |||
| ASA | 98.3 | 99.5 | 96.9 |
| Clopidogrel | 80.6 | 82.9 | 77.6 |
| Beta-blockers | 52.3 | 52.0 | 52.8 |
| Statins | 36.5 | 38.6 | 33.9 |
| UFH/LMWH | 100 | 100 | 100 |
| ACE inhibitors/ARBs | 68.2 | 68.6 | 67.7 |
| Cardiac catheterization (%) | 87.0 | 85.7 | |
| In-hospital coronary revascularization (%) | |||
| PCI | 50.7 | 62.4 | |
| CABG | 10.2 | 9.9 |
ACE, angiotensin-converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; ASA, aspirin; CABG, coronary artery bypass grafting; LMWH, low-molecular-weight heparin; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; UFH, unfractionated heparin.